Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.
van Lierop ZY, Wessels MH, Lekranty WM, Moraal B, Hof SN, Hogenboom L, de Jong BA, Meijs N, Mensing LA, van Oosten BW, Sol N, van Kempen ZL, Vermunt L, Willems MJ, Strijbis EM, Uitdehaag BM, Killestein J, Teunissen CE. van Lierop ZY, et al. Mult Scler. 2024 Nov;30(13):1620-1629. doi: 10.1177/13524585241277044. Epub 2024 Oct 17. Mult Scler. 2024. PMID: 39420574 Free PMC article.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
Toorop AA, van Lierop ZY, Gelissen LM, Hoitsma E, Zeinstra EM, van Rooij LC, van Munster CE, Vennegoor A, Mostert JP, Wokke BH, Kalkers NF, Hoogervorst EL, van Eijk JJ, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige L, Kloosterziel ME, Arnoldus EP, van Dijk GW, Bouvy WH, Wessels MH, Boonkamp L, Strijbis EM, van Oosten BW, De Jong BA, Lissenberg-Witte BI, Barkhof F, Moraal B, Teunissen CE, Rispens T, Uitdehaag BM, Killestein J, van Kempen ZL. Toorop AA, et al. Among authors: van lierop zy. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):392-400. doi: 10.1136/jnnp-2023-332119. J Neurol Neurosurg Psychiatry. 2024. PMID: 37963723 Clinical Trial.
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis.
Rodriguez-Mogeda C, van Lierop ZYGJ, van der Pol SMA, Coenen L, Hogenboom L, Kamermans A, Rodriguez E, van Horssen J, van Kempen ZLE, Uitdehaag BMJ, Teunissen CE, Witte ME, Killestein J, de Vries HE. Rodriguez-Mogeda C, et al. Among authors: van lierop zygj. J Neuroinflammation. 2023 Sep 26;20(1):215. doi: 10.1186/s12974-023-02900-z. J Neuroinflammation. 2023. PMID: 37752582 Free PMC article.
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
Wessels MH, Van Lierop ZY, Noteboom S, Strijbis EM, Heijst JA, Van Kempen ZL, Moraal B, Barkhof F, Uitdehaag BM, Schoonheim MM, Killestein J, Teunissen CE. Wessels MH, et al. Among authors: van lierop zy. Mult Scler. 2023 Sep;29(10):1229-1239. doi: 10.1177/13524585231188625. Epub 2023 Aug 2. Mult Scler. 2023. PMID: 37530045 Free PMC article.
The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis.
Toorop AA, van Lierop ZYGJ, Strijbis EMM, Teunissen CE, Barkhof F, Uitdehaag BMJ, van Kempen ZLE, Killestein J. Toorop AA, et al. Among authors: van lierop zygj. Mult Scler Relat Disord. 2022 Jan;57:103364. doi: 10.1016/j.msard.2021.103364. Epub 2021 Nov 1. Mult Scler Relat Disord. 2022. PMID: 35158470 Free article.
Project Y: The search for clues explaining phenotype variability in MS.
Loonstra FC, De Ruiter LRJ, Doesburg D, Lam KH, Van Lierop ZYGJ, Moraal B, Strijbis EMM, Killestein J, Uitdehaag BMJ. Loonstra FC, et al. Among authors: van lierop zygj. Mult Scler Relat Disord. 2022 Jan;57:103337. doi: 10.1016/j.msard.2021.103337. Epub 2021 Oct 16. Mult Scler Relat Disord. 2022. PMID: 35158448 Free article.
14 results